首页 | 本学科首页   官方微博 | 高级检索  
检索        


Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised,open-label phase 2 trial
Authors:Andrew X Zhu  Richard S Finn  Julien Edeline  Stephane Cattan  Sadahisa Ogasawara  Daniel Palmer  Chris Verslype  Vittorina Zagonel  Laetitia Fartoux  Arndt Vogel  Debashis Sarker  Gontran Verset  Stephen L Chan  Jennifer Knox  Bruno Daniele  Andrea L Webber  Scot W Ebbinghaus  Junshui Ma  Tatsuya Yamashita
Institution:1. Department of Medicine, Harvard Medical School, Boston, MA, USA;2. Massachusetts General Hospital Cancer Center, Boston, MA, USA;3. Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA;4. Department of Medical Oncology, Centre Eugène Marquis, Rennes, France;5. Department of Medical Oncology and Gastroenterology, Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France;6. Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan;7. Department of Medical Oncology, University of Liverpool, Liverpool, UK;8. Department of Hepatology, University Hospital Gasthuisberg, Leuven, Leuven, Belgium;9. Istituto Oncologico Veneto-Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padua, Italy;10. Department of Gastroenterology and Hepatology, Hôpital Universitaire Pitié-Salpêtrière, Paris, France;11. Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule, Hannover, Germany;12. Department of Medical Oncology, King''s College Hospital, London, UK;13. Gastrointestinal Oncology Unit, Hôpital Erasme, Brussels, Belgium;14. Department of Clinical Oncology, State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Shatin, Hong Kong;15. Department of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada;p. Department of Oncology, Azienda Ospedaliera Gaetano Rummo, Benevento, Italy;q. Department of Global Clinical Development, Merck & Co, Kenilworth, NJ, USA;r. Department of Medical Oncology, National Taiwan University Hospital, Taipei, Taiwan;s. Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan
Abstract:
Keywords:for the
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号